Socium Therapeutics, Inc.

Developing orally-administered cancer vaccine platform that stimulates the patient's immune system to kill cancer cells. Ready for PhI trial in prostate cancer.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Parsippany-Troy Hills, NJ, US
  • Currency USD
  • Founded December 2017
  • Employees 3
  • Incorporation Type C-corp
  • Website sociumtherapeutics.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free